Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms

Journal of the Neurological Sciences

Volumn 217, Issue 2, 2004, Pages 181-188

  Fainardi, Enrico ^a,b   Castellazzi, Massimiliano ^a   Casetta, Ilaria ^a   Cultrera, Rosario ^a   Vaghi, Luca ^a   Granieri, Enrico ^a   Contini, Carlo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Antibody affinity; Cerebrospinal fluid; Chlamydia pneumoniae; Intrathecal synthesis; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0346727230     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2003.09.012     Document Type: Article

References (36)

1. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343:2000;938-952.
2. Meinl E. Concepts of viral pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 12:1999;303-307.
3. Yucesan C., Sriram S. Chlamydia pneumoniae infection of the central nervous system. Curr. Opin. Neurol. 14:2001;355-359.
4. Sriram S., Stratton C.W., Yao S.Y., Tharp A., Ding L., Bannan J.D.et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46:1999;6-14.
5. Layh-Schmitt G., Bend C., Hildt U., Dong-Si T., Jüttler E., Schnitzler P.et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann. Neurol. 47:2000;652-655.
6. Treib J., Haaß A., Stille W., Maass M., Stephan C., Holzer G.et al. Multiple sclerosis and Chlamydia pneumoniae. Ann. Neurol. 47:2000;408.
7. Ikejima H., Haranaga S., Takemura H., Kamo T., Takahashi Y., Friedman H.et al. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluid. Clin. Diagn. Lab. Immunol. 8:2001;499-502.
8. Gieffers J., Poh D., Treib J., Dittmann R., Stephan C., Klotz K.et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann. Neurol. 49:2001;585-589.
9. Hao Q., Miyashita N., Matsui M., Wang H.Y., Matsushima T., Saida T. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis. Mult. Scler. 8:2002;436-440.
10. Boman J., Roblin P.M., Sundström P., Sandström M., Hammerschlag M.R. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology. 54:2000;265.
11. Pucci E., Taus C., Carthechini E., Morelli M., Giuliani G., Clementi M. et al. Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Ann. Neurol. 48:2000;340-399.
12. Saiz A., Marcos M.A., Graus F., Vidal J., Jimenez de Anta M.T. No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis. J. Neurol. 248:2001;617-618.
13. Derfuss T., Gürkov R., Bergh F.T., Goebels N., Hartmann M., Barz C.et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain. 124:2001;1325-1335.
14. Hammerschlag M.R., Ke Z., Lu F., Roblin P., Boman J., Kalman B. Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis? J. Clin. Microbiol. 38:2000;4274-4276.
15. Morré S.A., De Groot C.J.A., Killestein J., Meijer C.J.L.M., Polman C.H., Van der Valk P.et al. Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients? Ann. Neurol. 48:2000;399.
16. Lenz D.C., Lu L., Conant S.B., Wolf N.A., Gérard H.C., Whittum-Hudson J.A.et al. A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J. Immunol. 167:2001;1803-1808.
17. Krametter D., Niederwieser G., Berghold A., Birnbaum G., Strasser-Fuchs S., Hartung H.P.et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult. Scler. 7:2001;13-18.
18. Yao S.Y., Stratton C.W., Mitchell W.M., Sriram S. CSF oligoclonal bands in MS include antibodies against Chlamydiophila antigens. Neurology. 56:2001;1168-1176.
19. Sindic C.J.M., Monteyne P., Laterre E.C. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J. Neuroimmunol. 54:1994;75-80.
20. Conrad A.J., Chiang E.Y., Andeen L.E., Avolio C., Walker S.M., Baumhefner R.W.et al. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J. Neuroimmunol. 54:1994;99-108.
21. Luxton R.W., Zeman A., Holzel H., Harvey P., Wilson J., Kocen R.et al. Affinity of antigen-specific IgG distinguishes multiple sclerosis from encephalitis. J. Neurol. Sci. 132:1995;11-19.
22. Reiber H., Ungefehr S., Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult. Scler. 4:1998;111-117.
23. Poser C.M., Paty D.W., Scheimberger L., McDonald W.I., Davis F.A., Ebers G.C.et al. New diagnostic criteria for MS: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
24. Lublin D.F., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 46:1996;907-911.
25. Kurtzke J.F. Rating neurological impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology. 33:1983;1444-1452.
26. Salden H.J.M., Bas B.M., Hermas J.T.H., Janson P.C.V. Analytical performance of three commercially available nephelomethers compared quantifying protein in serum and cerebrospinal fluid. Clin. Chem. 34:1988;1594-1596.
27. Tibbling G., Link H., Öhman S. Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference value. Scand. J. Clin. Lab. Invest. 37:1977;385-390.
28. Contini C., Fainardi E., Seraceni S., Granieri E., Castellazzi M., Cultrera R. Molecular identification and antibody testing of Chlamydiophila pneumoniae in a subgroup of patients with HIV-associated dementia complex preliminary results. J. Neuroimmunol. 136:2003;172-177.
29. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin. Chem. 37:1991;1153-1160.
30. Reiber H., Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin. Chem. Acta. 163:1987;319-328.
31. Reiber H. Evaluation of blood cerebrospinal fluid barrier function and quantification of the humoral immune response within the central nervous system. Thompson E.J., Trojano M., Livrea P. Cerebrospinal fluid analysis in multiple sclerosis. 1996;51-72 Springer, Milano.
32. Sotgiu S., Piana A., Pugliatti M., Sotgiu A., Deiana G.A., Sgaramella E.et al. Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls. Mult. Scler. 7:2001;371-374.
33. Thompson A.J., Polman C.H., Miller D.H., Mc Donald W.I., Brochet B., Filippi M.et al. Primary progressive multiple sclerosis. Brain. 120:1997;1085-1096.
34. McDonnell G.V., Hawkins S.A. Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J. Neurol. Sci. 199:2002;1-15.
35. Hafler D.A. The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis. J. Clin. Invest. 104:1999;527-529.
36. Luxton R.W., Thompson E.J. Affinity distribution of antigen-specific IgG in patients with multiple sclerosis and in patients with viral encephalitis. J. Immunol. Methods. 131:1990;277-282.